Maaike J. Vos - Concepedia

Author

Maaike J. Vos

Medisch Centrum Haaglanden ORCID

Also Known As

M J Vos, M Vos, M. J. Vos, M. Vos, M.J. Vos, Maaike J. Vos, Maaike J Vos, Maaike J. Vos, Maaike Vos, Vos, M

Publications

1.3K

Citations

H-Index

Concepts

All Affiliations

Medisch Centrum Haaglanden Amsterdam UMC Location Vrije Universiteit Amsterdam Leiden University Medical Center Erasmus MC Amsterdam University Medical Centers

About

Maaike J. Vos is an author at Medisch Centrum Haaglanden specializing in neuro-oncology, medicine, and glioma.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	458
2	Neurology	5	5	364
3	Health Sciences	4	4	158
4	Social Sciences	1	1	180
5	Cell Biology	1	1	39

Maaike J. Vos

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
The course of neurocognitive functioning in high-grade glioma patients1 Ingeborg Bosma, Maaike J. Vos, J.J. Heimans, Neuro-Oncology NeuropsychologyHigh-grade GliomasBrain LesionCognitive RehabilitationGlioma	2006	180
Interobserver variability in the radiological assessment of response to chemotherapy in glioma Maaike J. Vos, Bernard M.J. Uitdehaag, Frederik Barkhof, Neurology	2003	93
Health-related quality of life of long-term high-grade glioma survivors Ingeborg Bosma, Jaap C. Reijneveld, Linda Douw, Neuro-Oncology Quality Of LifeLife AssessmentHealth-related QualityTumor RecurrenceCancer Management	2008	85
Internet-based guided self-help for glioma patients with depressive symptoms: a randomized controlled trial Florien Boele, Martin Klein, Irma M. Verdonck‐de Leeuw, Journal of Neuro-Oncology	2017	83
First‐line antiepileptic drug treatment in glioma patients with epilepsy: Levetiracetam vs valproic acid Pim B. van der Meer, Linda Dirven, Marta Fiocco, Epilepsia	2021	71
Seizure reduction in a low-grade glioma: more than a beneficial side effect of temozolomide Johan A F Koekkoek, Linda Dirven, J.J. Heimans, Journal of Neurology Neurosurgery & Psychiatry	2014	65
The impact of bevacizumab on health-related quality of life in patients treated for recurrent glioblastoma: Results of the randomised controlled phase 2 BELOB trial Linda Dirven, Martin J. van den Bent, Andrew Bottomley, European Journal of Cancer Neuro-oncologyOncologyHealth-related QualityCancer ManagementClinical Trials	2015	58
Comparison of 2D (RANO) and volumetric methods for assessment of recurrent glioblastoma treated with bevacizumab—a report from the BELOB trial Renske Gahrmann, Martin J. van den Bent, Bronno van der Holt, Neuro-Oncology	2017	51
Thallium-201 Single-Photon Emission Computed Tomography As an Early Predictor of Outcome in Recurrent Glioma Maaike J. Vos, Otto S. Hoekstra, Frederik Barkhof, Journal of Clinical Oncology	2003	45
Radiologic findings in patients treated with boron neutron capture therapy for glioblastoma multiforme within EORTC trial 11961 Maaike J. Vos, Bernd Turowski, Friedhelm E. Zanella, International Journal of Radiation OncologyBiologyPhysics Neuro-oncologyRadiation TherapyGlioblastoma MultiformeMedicineEortc Trial 11961	2005	42

Page 1